Breast Cancer Invasive
📧 Sign up to get email alerts when something new happens for Breast Cancer Invasive.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Receptive Music Therapy Effects on Anxiety, Depression, QoL, and EGF, IL-8, and NfL During the Breast Cancer Treatment. [NA]
An ongoing clinical trial is evaluating receptive music therapy to affect anxiety, depression, quality of life, and biomarkers (EGF, IL-8, N…
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: Precision Regional Node Irradiation for Sentinel Node-positive Breast Cancer [NA]
This entry provides an update on a trial evaluating precision regional node irradiation for sentinel node-positive breast cancer; the study …
-
CLINICAL_TRIALS trial_result · 2023-12-04Clinical Trial Update: Density Lowering Effect of "OFS Add on to TMX"(DELFINO Trial) [Phase 3]
Phase 3 trial update for the density-lowering effect of OFS add-on to TMX in invasive breast cancer (DELFINO). Status not yet available.
-
FDA approval · 2018-06-27FDA Approved: EVISTA — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for EVISTA (raloxifene hydrochloride) by Eli Lilly. The action updates the labeling with a new o…
-
FDA approval · 2016-04-08FDA Approved: RALOXIFENE HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved the original application for raloxifene hydrochloride (Amneal Pharmaceuticals LLC) as a generic, for postmenopausal osteoporosi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.